|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
20
|
|
pubmed:dateCreated |
2004-10-25
|
|
pubmed:abstractText |
This study was undertaken to determine whether low intratumoral doses of the epidermal growth factor receptor ligand-transforming growth factor alpha (TGF-alpha) fused to Pseudomonas exotoxin (TGF-alpha-PE38)-abrogated head and neck squamous cell carcinoma (HNSCC) tumor growth in vitro and in vivo.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
1078-0432
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
15
|
|
pubmed:volume |
10
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
7079-87
|
|
pubmed:dateRevised |
2009-11-19
|
|
pubmed:meshHeading |
pubmed-meshheading:15501988-Animals,
pubmed-meshheading:15501988-Carcinoma, Squamous Cell,
pubmed-meshheading:15501988-Dose-Response Relationship, Drug,
pubmed-meshheading:15501988-Exotoxins,
pubmed-meshheading:15501988-Head and Neck Neoplasms,
pubmed-meshheading:15501988-Humans,
pubmed-meshheading:15501988-Ligands,
pubmed-meshheading:15501988-Mice,
pubmed-meshheading:15501988-Mice, Nude,
pubmed-meshheading:15501988-Receptor, Epidermal Growth Factor,
pubmed-meshheading:15501988-Transplantation, Heterologous,
pubmed-meshheading:15501988-Tumor Cells, Cultured
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Abrogation of head and neck squamous cell carcinoma growth by epidermal growth factor receptor ligand fused to pseudomonas exotoxin transforming growth factor alpha-PE38.
|
|
pubmed:affiliation |
Department of Otolaryngology, University of Pittsburgh and the University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, P.H.S.
|
